Membership Benefits

Discounted Medication Prices
Virtual Hospital
Talk To A Doctor 24/7
Sexual Confidence For Men

Francais

Phone: 0845 459 9039
(7p per minute + network charges)
 
E-mail: support@uk-med.co.uk
Europe approves once-daily Cialis for impotence

Image European officials have approved a once-daily version of impotence pill Cialis...

LONDON, June 25 (Reuters)

The drug's maker, Eli Lilly and Co. (LLY.N: QuoteProfile , Research), said on Monday that the green light from the European Commission meant Cialis was the first erectile dysfunction medicine cleared for continuous use.

Until now, drugs such as Cialis and Pfizer Inc.'s (PFE.N: QuoteProfile , Research) rival product, Viagra, have been taken as needed.

The new low-dose formulation of Cialis, by contrast, is taken all the time, which eliminates the need to plan sex within a limited timeframe. It is aimed at men who anticipate sexual activity at least twice a week.

 

 

Lilly plans to start launching the once-daily version in certain European countries in the second half of 2007.

Cialis generated worldwide sales of $266 million in the first quarter of 2007, up 19 percent on a year earlier. The once-daily version could help Lilly differentiate its medicine from competitors, according to industry analysts.

 

Impotence Medications By manufacturer

Weight-Loss Medications by Manufacturer

advert
© 2018
155 Regents Park Road London NW1 8BB United Kingdom | Tel: 0845 459 9039 (7p per minute plus network charges) | support@uk-med.co.uk
MHRA Logo